Inhibikase Therapeutics (IKT) Current Assets (2020 - 2026)
Inhibikase Therapeutics (IKT) reported Current Assets of $162.34 million for Q2 2026, up 82.8% from $88.79 million a year earlier but down 5.7% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Inhibikase Therapeutics posted Current Assets of $180.11 million, up 82.9% from FY2024.
- Current Assets has a five-year compound annual growth rate of 64.9% (FY2020 to FY2025).
- By year, Current Assets came in at $98.45 million in FY2024 (+592.8%), $14.21 million in FY2023 (-41.7%), $24.37 million in FY2022 (-42.6%) and $42.47 million in FY2021 (+187.3%).
- Five-year quarterly Current Assets spans a low of $4.19 million in Q3 2024 and a high of $180.11 million in Q4 2025.
- Year over year, Current Assets has now increased in each of the last three quarters, with growth averaging 352.7% over the last seven quarters.
- The high point for year-over-year Current Assets in five years was Q2 2025 (growth of 932.2%); the low point was Q3 2024 (a decline of 76.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $172.18 million (Q1 2026), $180.11 million (Q4 2025) and $78.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Inhibikase Therapeutics | 357.87 Mn | -227.60 Mn | - | 162.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 162.34 Mn |
| Mar 31, 2026 | 172.18 Mn |
| Dec 31, 2025 | 180.11 Mn |
| Sep 30, 2025 | 78.54 Mn |
| Jun 30, 2025 | 88.79 Mn |
| Mar 31, 2025 | 94.16 Mn |
| Dec 31, 2024 | 98.45 Mn |
| Sep 30, 2024 | 4.19 Mn |
| Jun 30, 2024 | 8.60 Mn |
| Mar 31, 2024 | 10.81 Mn |
| Dec 31, 2023 | 14.21 Mn |
| Sep 30, 2023 | 17.55 Mn |
| Jun 30, 2023 | 21.98 Mn |
| Mar 31, 2023 | 27.63 Mn |
| Dec 31, 2022 | 24.37 Mn |
| Sep 30, 2022 | 27.99 Mn |
| Jun 30, 2022 | 33.95 Mn |
| Dec 31, 2021 | 42.47 Mn |
| Mar 31, 2021 | 11.87 Mn |
| Dec 31, 2020 | 14.78 Mn |
API Access
Inhibikase Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();